Drugs / Meningococcal A, C, Y and W-135 conjugate vaccine
Meningococcal A, C, Y and W-135 conjugate vaccine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05480800 Comparator | Sep 2022 → Sep 2024 | salmonellosis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal A, C, Y and W-135 conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05480800 ↗ |
| Modality | Vaccine | “Meningococcal A, C, Y and W-135 conjugate vaccine” NCT05480800 ↗ |